Cytology assessment can predict survival for patients with metastatic pancreatic neuroendocrine neoplasms
Sigel C, Guo H, Sigel K, Zhang M, Rekhtman N, Lin O, Klimstra D, Jungbluth A, Tang L. Cytology assessment can predict survival for patients with metastatic pancreatic neuroendocrine neoplasms. Cancer Cytopathology 2017, 125: 188-196. PMID: 28094897, PMCID: PMC5352475, DOI: 10.1002/cncy.21817.Peer-Reviewed Original ResearchConceptsConcurrent core needle biopsyMetastatic pancreatic neuroendocrine neoplasmsCore needle biopsyPancreatic neuroendocrine neoplasmsKi-67 indexNeedle biopsyNeuroendocrine neoplasmsKi-67Cell blocksCytological differentiationFine-needle aspirationKi-67 assessmentPredictive of survivalPredictors of outcomeStage-adjusted analysisGrading of pancreatic neuroendocrine neoplasmsMedian survivalCytological gradeNeuroendocrine tumorsCytology specimensCytologic smearsPredicting PrognosisCytological assessmentGrade 3Well-differentiated
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply